Seth Sheldon, MD
Clinical Cardiac Electrophysiology · Kansas City, KSNPI 1245488899
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (44.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 24 manufacturers reported payments, led by Boston Scientific at 38.3% of the total.
Across 299 payments — averaging $214.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$25K
- Medtronic$18K
- Abbott$8K
- Biosense Webster, Inc.$8K
- Altathera Pharmaceuticals LLC$2K
- Stereotaxis Inc$962
- plus $3K from 18 others
Across 37 payments — averaging $2542.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$94K
What the payments were for
- Consulting fees$14,28322%
- Speaking & faculty fees$28,37544%
- Travel & lodging$7,47912%
- Food & beverage$14,07822%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 63 | $24,575 |
| Medtronic(2 entities) | 103 | $17,798 |
| Abbott | 38 | $8,374 |
| Biosense Webster, Inc. | 27 | $7,601 |
| Altathera Pharmaceuticals LLC | 2 | $2,074 |
| Stereotaxis Inc | 4 | $962 |
| AOP Health US, LLC | 1 | $713 |
| Biotronik Inc. | 12 | $631 |
| Impulse Dynamics (USA) Inc. | 2 | $282 |
| Irhythm Technologies, Inc. | 7 | $272 |
| Philips North America LLC | 5 | $221 |
| Atricure, Inc. | 2 | $115 |
| Pfizer | 6 | $112 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $96 |
| Sanofi-aventis U.S. LLC | 3 | $65 |
| Novartis | 4 | $62 |
| Novo Nordisk | 3 | $54 |
| Johnson & Johnson(2 entities) | 2 | $49 |
| Amgen | 3 | $44 |
| E.r. Squibb & Sons, L.L.C. | 3 | $40 |
| Cardiva Medical, Inc. | 1 | $25 |
| Merck | 1 | $19 |
| Stryker | 1 | $17 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL - THERAPIES$11,747
- Farapulse$5,273
- EnSite Precision Cardiac Mapping System$2,975
- ENSITE$2,146
- Sotalol Hydrochloride$2,000
- ENSITE PRECISION$1,488
- Rapiblyk$1,426
- Carto 3$1,150
- Micra$915
- Niobe$885
- OPTIMIZER$564
- COBALT DR MRI SURESCAN$510
- WATCHMAN FLX$407
- QDOT MICRO Catheter$395
- WATCHMAN Access System$390
- OCTARAY MAPPING CATHETER$291
- Advisor Catheter$273
- AVEIR$263
- Pentaray$249
- CryoConsole$187
How this compares
$64,215 in reported general payments places this provider in the 80th percentile of 37 clinical cardiac electrophysiology providers in Kansas.
See all clinical cardiac electrophysiology providers in Kansas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 468 | $471,358 |
| XareltoRivaroxaban | 203 | $187,171 |
| MultaqDronedarone Hcl | 33 | $45,530 |
| Dofetilide | 127 | $14,801 |
| Mexiletine Hcl | 85 | $11,318 |
| Flecainide Acetate | 196 | $8,414 |
| SavaysaEdoxaban Tosylate | 12 | $5,737 |
| Metoprolol Succinate | 402 | $5,057 |
| SotalolSotalol Hcl | 57 | $1,820 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 77 | $1,624 |
| Carvedilol | 104 | $1,053 |
| Enoxaparin Sodium | 18 | $888 |
| Atorvastatin Calcium | 100 | $868 |
| Losartan Potassium | 71 | $672 |
| Rosuvastatin Calcium | 37 | $653 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $112 | $471,358468 claims |
| Johnson & JohnsonXarelto | $49 | $187,171203 claims |
| Sanofi-aventis U.S. LLCMultaq | $65 | $45,53033 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 37 clinical cardiac electrophysiology providers in Kansas.
Other clinical cardiac electrophysiology in Kansas City
- Dhanunjaya LakkireddyKansas City$1.1M
- Rhea PimentelKansas City$163K
- Yeruva Veera Madhu Mohan ReddyKansas City$122K
- Martin EmertKansas City$69K
- Anila RaoKansas City$57K
- Raghuveer DendiKansas City$53K
- Ninad NadkarniKansas City$52K
- Rigoberto RamirezKansas City$32K
- Siva Kumar SomaKansas City$23K
- Neil PhillipsKansas City$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.